Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA-IV Analysis of the OVCAD Data

Stephan Polterauer, Ignace Vergote, Nicole Concin, Ioana Braicu, Radoslav Chekerov, Sven Mahner, Linn Woelber, Isabelle Cadron, Toon Van Gorp, Robert Zeillinger, Dan Cacsire Castillo-Tong, Jalid Sehouli

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)380-385
JournalInternational Journal of Gynecological Cancer
Volume22
Issue number3
DOIs
Publication statusPublished - Mar 2012

Keywords

  • Ovarian cancer
  • Cytoreductive surgery
  • Residual disease
  • Optimal cytoreduction
  • Prognosis

Cite this

Polterauer, S., Vergote, I., Concin, N., Braicu, I., Chekerov, R., Mahner, S., Woelber, L., Cadron, I., Van Gorp, T., Zeillinger, R., Castillo-Tong, D. C., & Sehouli, J. (2012). Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA-IV Analysis of the OVCAD Data. International Journal of Gynecological Cancer, 22(3), 380-385. https://doi.org/10.1097/IGC.0b013e31823de6ae